Kidney Disease Clinical Trials

Showing 801-820 of 1,850 trials

Dialysis Training Therapy: The DiaTT Trial

NCT03885102

DiaTT is an interventional, cluster-randomized (1:1), multicenter trial for patients with chronic kidney disease undergoing hemodialysis (n=1,100). This trial will test the effectiveness (by change of sit-to-stand test between baseline and 12 months) of intradialytic exercise training (ET) and health literacy counseling (HLC) for 12 months (Intervention group) in comparison to control group (usual care, UC; no ET, no HLC).

Chronic Kidney DiseasesHemodialysis

Prof. Dr. med. Martin Halle1,211 participantsStarted Apr 2019

Amberg, Bavaria, Germany • Aschaffenburg, Bavaria, Germany • Bamberg, Bavaria, Germany +18 more locations

COMPLETEDEARLY_PHASE1

Effects of Shenkang Decoction on Creatinine and Blood Urea Nitrogen in Chronic Renal Failure Hemodialysis Patients

NCT05631782

To explore the clinical effect of Shenkang Decoction in chronic renal failure (CRF) patients with hemodialysis (HD).

Chronic Renal FailureHemodialysis

The First People's Hospital of Zunyi160 participantsStarted Nov 2020

Zunyi, China

Dialysis Training Therapy: The DiaTT Trial

Effects of Shenkang Decoction on Creatinine and Blood Urea Nitrogen in Chronic Renal Failure Hemodialysis Patients

Related Searches

Living With CKD: An E-Learning Platform for Adolescents With CKD About the Disease and Its Management

Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease

Efficacy of Targeted Abdominal Perfusion Pressure in Septic Shock

Graft-first Versus Fistula-first in Older Patients With End-stage Kidney Disease

A Single Arm, Multi-Center Study To Evaluate The Intelligent Dialysis Assistant (IDA)

Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Extended-Release (HC-ER) in Subjects With Renal Impairment

Pharmacokinetics and Pharmacodynamics Assessment of Drug Eritromax Compared to Eprex in Healthy Subjects.

Yorkshire Kidney Screening Trial

Sarcopenia and Risk of Falls in Patients With Major Chronic Diseases

AQP-1 Polymorphism on Fluid Status in Hemodialysis Patients

Nitazoxanide Pharmacokinetic Parameters in Renal Impaired Subjects

A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma

SOP's for CKD-MBD-Biomarkers

Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250

Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma

Tele-palliative Care in Rural Dialysis Patients

Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa

Impact of IDPN on Nutrition Markers in Patients Receiving ICHD